Unbiased News Awaits.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Memorial Day
Harvard
Baseball
Education
NCAA
Social Media
Artificial Intelligence
Donald Trump
Soccer
European Union
Senate
Natural Disasters
Published • loading... • Updated

Topline results from phase 2b clinical trial of UBX1325 for DME expected in Q1 2025

Summary by modernretina.com
This phase 2b study (ASPIRE) is currently underway.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
modernretina.commodernretina.com

Topline results from phase 2b clinical trial of UBX1325 for DME expected in Q1 2025

This phase 2b study (ASPIRE) is currently underway.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

modernretina.com broke the news in on Saturday, January 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

San Francisco, California

San Francisco, California

News
For You
SearchBlindspotLocal